Literature DB >> 22379244

Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys.

Maria Calem1, Jatinder Bisla, Aysha Begum, Michael Dewey, Paul E Bebbington, Traolach Brugha, Claudia Cooper, Rachel Jenkins, James Lindesay, Sally McManus, Howard Meltzer, Nicola Spiers, Scott Weich, Robert Stewart.   

Abstract

STUDY
OBJECTIVES: To investigate changes over 15 years in the prevalence of insomnia and its association with demographic characteristics and hypnotic medication use.
DESIGN: Analysis of 3 cross-sectional national mental health surveys carried out in 1993, 2000, and 2007, which used comparable sampling methods and identical insomnia assessments.
SETTING: Adults living in private households in England. PATIENTS OR PARTICIPANTS: 20,503 people aged 16-64 years. MEASUREMENTS AND
RESULTS: Insomnia was defined according to 4 different criteria, using relevant questions from the revised Clinical Interview Schedule. Modest increases in insomnia prevalence were found over the survey periods (any symptoms increasing from 35.0% in 1993 to 38.6% in 2007; insomnia diagnosis from 3.1% to 5.8%, respectively). In all 3 surveys, similar strengths of association in relation to all criteria were found, with female gender, increased age, lower educational attainment, depression, unemployment, economic inactivity, and widowed, divorced, or separated status. Prevalence of hypnotic use was double in 2000 (0.8%) compared to 1993 (0.4%); from limited information on selected medications, there was no such increase between 2000 and 2007. The reasons reported for any sleep disturbance over the last month were generally similar across surveys, the most marked change being illness/discomfort increasing as an explanation from 14.3% to 17.4% to 19.0%.
CONCLUSIONS: In the English general population, insomnia (by any definition) showed a modest but steady increase in prevalence over a 15-year period. Strengths of associations with demographic factors and self-reported reasons for sleep disturbance remained reasonably stable over this period.

Entities:  

Keywords:  Insomnia; hypnotic use; national survey; sleep; trends

Mesh:

Substances:

Year:  2012        PMID: 22379244      PMCID: PMC3274339          DOI: 10.5665/sleep.1700

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  16 in total

1.  The nature of insomnia and the need to refine our diagnostic criteria.

Authors:  C M Morin
Journal:  Psychosom Med       Date:  2000 Jul-Aug       Impact factor: 4.312

2.  Treating insomnia.

Authors:  Anne M Holbrook
Journal:  BMJ       Date:  2004-11-20

Review 3.  Participation rates in epidemiologic studies.

Authors:  Sandro Galea; Melissa Tracy
Journal:  Ann Epidemiol       Date:  2007-06-06       Impact factor: 3.797

Review 4.  Societal costs of insomnia.

Authors:  Damien Léger; Virginie Bayon
Journal:  Sleep Med Rev       Date:  2010-03-31       Impact factor: 11.609

Review 5.  Evaluation of chronic insomnia. An American Academy of Sleep Medicine review.

Authors:  M J Sateia; K Doghramji; P J Hauri; C M Morin
Journal:  Sleep       Date:  2000-03-15       Impact factor: 5.849

6.  Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers.

Authors:  G Lewis; A J Pelosi; R Araya; G Dunn
Journal:  Psychol Med       Date:  1992-05       Impact factor: 7.723

7.  Trends in service use and treatment for mental disorders in adults throughout Great Britain.

Authors:  Traolach S Brugha; Paul E Bebbington; Nicola Singleton; David Melzer; Rachel Jenkins; Glyn Lewis; Michael Farrell; Dinesh Bhugra; Alison Lee; Howard Meltzer
Journal:  Br J Psychiatry       Date:  2004-11       Impact factor: 9.319

8.  Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years.

Authors:  Robert Stewart; Alain Besset; Paul Bebbington; Traolach Brugha; James Lindesay; Rachel Jenkins; Nicola Singleton; Howard Meltzer
Journal:  Sleep       Date:  2006-11       Impact factor: 5.849

9.  Epidemiology of insomnia: what we know and what we still need to learn.

Authors:  Maurice M Ohayon
Journal:  Sleep Med Rev       Date:  2002-04       Impact factor: 11.609

10.  Epidemiology of insomnia: a longitudinal study in a UK population.

Authors:  Hannah Morphy; Kate M Dunn; Martyn Lewis; Helen F Boardman; Peter R Croft
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

View more
  39 in total

1.  Maybe it's quality not length that matters.

Authors:  Nicholas Glozier
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

2.  Prescription of Zolpidem and the Risk of Fatal Motor Vehicle Collisions: A Population-Based, Case-Crossover Study from South Korea.

Authors:  Bo Ram Yang; Ye-Jee Kim; Mi-Sook Kim; Sun-Young Jung; Nam-Kyong Choi; Byungkwan Hwang; Byung-Joo Park; Joongyub Lee
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

3.  Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries.

Authors:  Anthony F Jorm; Scott B Patten; Traolach S Brugha; Ramin Mojtabai
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).

Authors:  Sandra Nordmann; Caroline Lions; Antoine Vilotitch; Laurent Michel; Marion Mora; Bruno Spire; Gwenaelle Maradan; Alain Morel; Perrine Roux; M Patrizia Carrieri
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

5.  A prospective questionnaire study in 100 healthy sleepers: non-bothersome forms of recognizable sleep disorders are still present.

Authors:  Birgit Frauscher; Thomas Mitterling; Aleke Bode; Laura Ehrmann; David Gabelia; Marlene Biermayr; Arthur Scott Walters; Werner Poewe; Birgit Högl
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

6.  Insomnia associated with traffic noise and proximity to traffic-a cross-sectional study of the Respiratory Health in Northern Europe III population.

Authors:  Emma Janson; Ane Johannessen; Mathias Holm; Karl Franklin; Gitte Juel Holst; Thorarinn Gislason; Rain Jögi; Eva Lindberg; Magnus Svartengren; Christer Janson
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

7.  Insomnia and its association with hypertension in a community-based population in China: a cross-sectional study.

Authors:  Yiqiang Zhan; Ruoqing Chen; Fen Zhang; Jinsong Wang; Yihong Sun; Rongjing Ding; Dayi Hu; Jinming Yu
Journal:  Heart Asia       Date:  2014-06-21

8.  Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012.

Authors:  Earl S Ford; Timothy J Cunningham; Wayne H Giles; Janet B Croft
Journal:  Sleep Med       Date:  2015-01-14       Impact factor: 3.492

Review 9.  Insomnia and cognitive behavioural therapy-how to assess your patient and why it should be a standard part of care.

Authors:  Kirstie N Anderson
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

10.  A decade's difference: 10-year change in insomnia symptom prevalence in Canada depends on sociodemographics and health status.

Authors:  Sheila N Garland; Hillary Rowe; Lily M Repa; Ken Fowler; Eric S Zhou; Michael A Grandner
Journal:  Sleep Health       Date:  2018-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.